The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers-Reference-Cited by-同舟云学术

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

Published:2006-08-08 Issue:1 Volume:102 Page:43-49
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Marcom P. Kelly,Isaacs Claudine,Harris Lyndsay,Wong Zee Wang,Kommarreddy Aruna,Novielli Nellie,Mann Gretchen,Tao Yu,Ellis Matthew J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-006-9307-8.pdf

Reference18 articles.

1. Slamon DJ, Godolphin W, Jones LA et al (1989) Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712

2. Marty M, Cognetti F, Maraninchi D et al (2005) Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group. J Clin Oncol 23:4265–4274

3. Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783–792

4. Piccart-Gebhart MJ, Procter M, Leyland-Jones B et al (2005) Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 353:1659–1672

5. Ellis M (2004) Overcoming endocrine therapy resistance by signal transduction inhibition. Oncologist 9 Suppl 3:20–26

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nutrition Intervention and Microbiome Modulation in the Management of Breast Cancer;Nutrients;2024-08-10

2. Resistance to hormone therapy in breast cancer cells promotes autophagy and EGFR signaling pathway;American Journal of Physiology-Cell Physiology;2023-09-01

3. Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer;npj Breast Cancer;2023-05-31

4. Human epidermal growth factor receptor-2 and endocrine resistance in hormone-dependent breast cancer;Endocrine-Related Cancer;2022-08-01

5. Clinical Efficacy of Trastuzumab, Pertuzumab and Docetaxel as First-Line Treatment for Metastatic Triple-Positive Breast Cancer;Advances in Clinical Medicine;2022